Zhigarev, D.; Varshavsky, A.; MacFarlane, A.W., IV; Jayaguru, P.; Barreyro, L.; Khoreva, M.; Dulaimi, E.; Nejati, R.; Drenberg, C.; Campbell, K.S.
Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology. Cancers 2022, 14, 3352.
https://doi.org/10.3390/cancers14143352
AMA Style
Zhigarev D, Varshavsky A, MacFarlane AW IV, Jayaguru P, Barreyro L, Khoreva M, Dulaimi E, Nejati R, Drenberg C, Campbell KS.
Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology. Cancers. 2022; 14(14):3352.
https://doi.org/10.3390/cancers14143352
Chicago/Turabian Style
Zhigarev, Dmitry, Asya Varshavsky, Alexander W. MacFarlane, IV, Prathiba Jayaguru, Laura Barreyro, Marina Khoreva, Essel Dulaimi, Reza Nejati, Christina Drenberg, and Kerry S. Campbell.
2022. "Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology" Cancers 14, no. 14: 3352.
https://doi.org/10.3390/cancers14143352
APA Style
Zhigarev, D., Varshavsky, A., MacFarlane, A. W., IV, Jayaguru, P., Barreyro, L., Khoreva, M., Dulaimi, E., Nejati, R., Drenberg, C., & Campbell, K. S.
(2022). Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology. Cancers, 14(14), 3352.
https://doi.org/10.3390/cancers14143352